Transforming growth factor-beta in intestinal epithelial differentiation and neoplasia (review)
- PMID: 2697192
Transforming growth factor-beta in intestinal epithelial differentiation and neoplasia (review)
Abstract
Transforming growth factor beta (TGF-beta is a multifunctional regulator of cell growth. It has become increasingly clear that TGF-beta action depends on the responsive cell types. Thus TGF-beta stimulates proliferation of mesenchymal cells and, in contrast, inhibits the growth of a large variety of epithelial cells. Recent studies, albeit controversial, support the notion that a gradient in mRNA transcripts encoding TGF-beta is maintained along the crypt-villus continuum of the small intestine in close correlation with the stage of differentiation of the enterocyte. Exogenous TGF-beta has been shown to inhibit the proliferation of a non-transformed rat jejunal crypt cell line. Additional salient findings have indicated that colon carcinoma cell lines recalcitrant to the restraining action of TGF-beta on proliferation are poorly differentiated, and that moderately differentiated colon tumor lines do retain, at least partly, their responsiveness to TGF-beta. To the best of our knowledge, no evidence is available pertaining to a contributory role of TGF-beta in the signalling mechanisms regulating growth and differentiation of normal colonic epithelial cells. In addition, we are ignorant of whether the interesting findings related to a functional relationship between TGF-beta and colon carcinoma cells lines (vide supra) are applicable to colonic preneoplastic and tumor cells in their natural habitat. In this review, we dwell on the available facts and missing observations, and present conceivable hypotheses pertaining to a putative role of TGF-beta in colon differentiation and neoplasia.
Similar articles
-
Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.Cell Growth Differ. 1999 Jan;10(1):11-8. Cell Growth Differ. 1999. PMID: 9950213
-
Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.Cancer Res. 1988 Feb 15;48(4):850-5. Cancer Res. 1988. PMID: 3276400
-
PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.Cancer Res. 2003 Apr 1;63(7):1568-75. Cancer Res. 2003. PMID: 12670906
-
[Growth factors and intestinal cancers].Bull Cancer. 1992;79(5):427-49. Bull Cancer. 1992. PMID: 1421706 Review. French.
-
The role for transforming growth factor-beta (TGF-beta) in human cancer.Crit Rev Oncog. 1999;10(4):303-60. Crit Rev Oncog. 1999. PMID: 10654929 Review.
Cited by
-
IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells.Clin Exp Immunol. 1998 Jan;111(1):152-7. doi: 10.1046/j.1365-2249.1998.00481.x. Clin Exp Immunol. 1998. PMID: 9472675 Free PMC article.
-
Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon carcinogenesis.J Cell Biol. 2002 Jun 10;157(6):915-20. doi: 10.1083/jcb.200201127. Epub 2002 Jun 10. J Cell Biol. 2002. PMID: 12058013 Free PMC article.
-
Presence of two signaling TGF-beta receptors in human pancreatic cancer correlates with advanced tumor stage.Dig Dis Sci. 1997 Oct;42(10):2054-63. doi: 10.1023/a:1018814416903. Dig Dis Sci. 1997. PMID: 9365135
-
Expression of MHC antigens by intestinal epithelial cells. Effect of transforming growth factor-beta 2 (TGF-beta 2).Clin Exp Immunol. 1995 Feb;99(2):240-4. doi: 10.1111/j.1365-2249.1995.tb05539.x. Clin Exp Immunol. 1995. PMID: 7851018 Free PMC article.
-
Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas.Jpn J Cancer Res. 1992 Jan;83(1):86-92. doi: 10.1111/j.1349-7006.1992.tb02356.x. Jpn J Cancer Res. 1992. PMID: 1312080 Free PMC article.